![](/img/cover-not-exists.png)
PCN148 COST-UTILITY OF ENTRECTINIB VERSUS CRIZOTINIB IN ROS1+ NSCLC PATIENTS: AN AUC MODEL ADAPTED TO ITALIAN CLINICAL PRACTICE
Bellone, M., Zaniolo, O., Martinelli, E., Marcelli, G., Orfanos, P., Pradelli, L.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.344
Date:
November, 2019
File:
PDF, 381 KB
2019